Powerful ACE 031 Peptide: Complete Research & Scientific Guide

ace 031 peptide is an experimental ActRIIB-Fc fusion protein that has been investigated for its ability to influence signaling pathways involved in skeletal-muscle regulation. Although it is commonly described online as an “ACE-031 peptide,” it is more accurately classified as a soluble activin receptor type IIB (ActRIIB) fusion protein rather than a conventional short peptide.

ACE-031 has attracted significant scientific interest because ActRIIB participates in signaling involving myostatin (GDF-8), activins, and other members of the transforming growth factor-beta (TGF-β) superfamily. Research has examined its molecular mechanism, effects on muscle biology, pharmacological characteristics, and potential applications in conditions associated with muscle loss.

What Is ACE-031?

ACE-031 was developed as a soluble form of the ActRIIB receptor fused to the Fc portion of human IgG1. This design allows the molecule to interact with selected extracellular ligands involved in ActRIIB signaling.

Unlike a selective myostatin inhibitor, ACE-031 can affect signaling involving multiple ActRIIB-associated ligands. This broader mechanism is an important consideration when interpreting research findings.

Scientific interest in ACE-031 has primarily centered on:

• Myostatin and GDF-8 research
• ActRIIB receptor biology
• Skeletal-muscle regulation
• Muscle-fiber research
• TGF-β superfamily signaling
• Muscle-wasting research
• Pharmacokinetic and pharmacodynamic studies

ACE-031 Structure and Molecular Characteristics

The molecular structure of ace 031 peptide is important for understanding its biological behavior.

ace 031 peptide contains the extracellular ligand-binding region of ActRIIB connected to an IgG1-Fc domain. The resulting fusion protein is substantially larger and structurally different from a conventional peptide.

Researchers evaluating ACE-031 should therefore consider:

• Molecular identity
• ActRIIB-Fc composition
• Molecular weight
• Protein purity
• Structural characterization
• Batch information
• Analytical testing
• Formulation
• Storage conditions

Because ACE-031 is a fusion protein, appropriate protein-characterization methods are particularly important when evaluating research material.

How Does ACE 031 Peptide Work?

ACE-031 functions as a soluble ligand-binding form of ActRIIB.

The normal ActRIIB receptor participates in signaling initiated by several extracellular proteins. ACE-031 can bind certain ligands before they interact with cell-surface receptors, potentially modifying downstream signaling.

This mechanism has been investigated in relation to:

• Myostatin signaling
• Activin signaling
• Skeletal-muscle growth regulation
• Muscle-cell biology
• TGF-β-superfamily pathways

The broader ligand-binding activity of ACE-031 is one of the most important characteristics distinguishing it from compounds designed to selectively inhibit myostatin.

ACE 031 Peptide and Myostatin Research

Myostatin, also known as growth differentiation factor-8 (GDF-8), is a member of the TGF-β superfamily and acts as an important regulator of skeletal-muscle development.

Because ActRIIB participates in myostatin signaling, researchers have investigated whether blocking or modifying this pathway can alter muscle-related biological processes.

ACE-031 became particularly interesting as an experimental model because it can interact with the ActRIIB signaling system rather than targeting myostatin alone.

This provides researchers with an opportunity to study:

• Myostatin biology
• ActRIIB ligand interactions
• Muscle-cell signaling
• Muscle-fiber development
• Regulation of muscle mass

ACE-031 and ActRIIB Signaling

Activin receptor type IIB (ActRIIB) is a cell-surface receptor involved in signaling from several TGF-β-superfamily ligands.

When relevant ligands interact with ActRIIB-containing receptor complexes, intracellular signaling can influence gene expression and cellular behavior.

ACE-031 was designed to function outside the cell as a soluble ligand-binding molecule. This allows researchers to investigate what happens when ActRIIB-related signaling is altered at the extracellular level.

Understanding this mechanism is important for research into:

• Receptor biology
• Ligand-receptor interactions
• Intracellular signaling
• Muscle regulation
• TGF-β-superfamily biology

ACE-031 and TGF-β Superfamily Research

The TGF-β superfamily contains numerous signaling proteins involved in development, cellular differentiation, tissue regulation, and metabolism.

ActRIIB can participate in signaling involving several members of this family, including myostatin and activins.

Consequently, ACE-031 research is broader than simply studying muscle growth. Researchers can use this system to investigate how changing ActRIIB ligand availability influences different biological pathways.

This broader mechanism is also important when interpreting safety and pharmacological findings.

ACE-031 and Skeletal-Muscle Research

One of the primary areas of interest surrounding ACE-031 is skeletal-muscle biology.

Preclinical studies have reported increases in skeletal-muscle mass and changes in muscle-fiber characteristics following ActRIIB pathway manipulation. These findings helped establish ACE-031 as a useful experimental model for investigating mechanisms that regulate muscle development.

Researchers may examine:

• Muscle mass
• Muscle-fiber cross-sectional area
• Muscle composition
• Muscle signaling
• Lean body mass
• Functional muscle measurements

Animal findings should, however, be interpreted separately from evidence obtained in human studies.

ACE-031 and Muscle-Fiber Research

Muscle-fiber analysis provides another important way of studying ActRIIB signaling.

Experimental research has investigated changes in muscle-fiber cross-sectional area following ACE-031 exposure. These measurements can provide information about how manipulation of ActRIIB-associated signaling influences skeletal-muscle structure.

Such research may involve:

• Histological analysis
• Fiber-size measurements
• Fiber-type characterization
• Muscle morphology
• Molecular markers of muscle development

These techniques can help researchers connect molecular signaling with observable changes in muscle tissue.

ACE-031 and Lean Body Mass Research

Human research has also examined changes in lean body mass and muscle volume.

An early randomized clinical study involving healthy postmenopausal women evaluated single doses of ACE-031 and reported dose-related pharmacodynamic findings, including changes in lean mass and thigh muscle volume at the highest dose studied.

These findings are scientifically relevant because they provide human data on the biological effects of ActRIIB pathway modulation.

They should not, however, be interpreted as establishing ACE-031 as an approved treatment.

ACE-031 Preclinical Research

Preclinical studies played an important role in the development of ACE-031 research.

Animal models provided evidence that ActRIIB ligand sequestration could influence skeletal-muscle mass and muscle-fiber characteristics. These experiments helped researchers investigate the relationship between myostatin-related signaling and muscle development.

Preclinical studies can provide valuable mechanistic information, but results from animals do not necessarily predict human safety or effectiveness.

ACE-031 Human Clinical Research

ACE-031 progressed beyond laboratory and animal studies into human clinical investigation.

An early placebo-controlled study evaluated ACE-031 in healthy postmenopausal women. Researchers examined safety, pharmacokinetics, pharmacodynamics, and changes in muscle-related measurements.

The study demonstrated that the compound could produce measurable biological effects, helping researchers better understand ActRIIB pathway modulation in humans.

However, subsequent research highlighted important safety considerations.

ACE-031 and Duchenne Muscular Dystrophy Research

ACE-031 was investigated in boys with Duchenne muscular dystrophy (DMD) because DMD is characterized by progressive skeletal-muscle degeneration.

A randomized clinical study evaluated ACE-031 for safety and biological effects. The study was discontinued because of safety concerns, including epistaxis (nosebleeds) and telangiectasias.

This clinical history is an essential part of any scientifically responsible ACE-031 page.

It demonstrates why promising biological activity does not necessarily translate into an acceptable therapeutic profile.

ACE-031 Safety and Research Limitations

ACE-031 research should be interpreted carefully because its mechanism affects a broader signaling network rather than one isolated molecule.

Clinical research identified safety concerns, particularly vascular-related adverse events such as nosebleeds and telangiectasias.

Researchers should therefore consider:

• Target specificity
• Effects on multiple ligands
• Dose-dependent responses
• Off-target biological consequences
• Clinical safety findings
• Differences between animal and human research

Presenting these limitations improves the scientific quality and credibility of an ACE-031 research page.

ACE-031 Research Applications

Myostatin Research

ACE-031 can be used as an experimental model for investigating the biological effects of modifying myostatin-related signaling.

ActRIIB Research

Its structure makes it particularly relevant to studies of ActRIIB ligand interactions and receptor biology.

Skeletal-Muscle Research

Researchers can investigate how ActRIIB signaling influences muscle mass, muscle fibers, and muscle development.

TGF-β Signaling Research

ACE-031 provides a model for examining signaling involving multiple members of the TGF-β superfamily.

Muscle-Wasting Research

ACE-031 has been investigated in experimental and clinical contexts involving diseases associated with muscle loss.

Key Research Benefits of ACE-031

Investigates ActRIIB Biology

ACE-031 provides researchers with a useful experimental model for studying ActRIIB-associated ligand signaling.

Supports Myostatin Research

Its mechanism allows researchers to investigate pathways involving myostatin and GDF-8.

Enables Muscle-Related Studies

Preclinical and clinical research has examined its effects on muscle-related measurements.

Helps Explore TGF-β Signaling

The compound provides an opportunity to study a broader network of TGF-β-superfamily signaling.

Provides Translational Research Information

ACE-031 has been studied from preclinical models through human clinical investigation, providing researchers with information across multiple stages of development.

ACE-031 vs. Selective Myostatin Inhibitors

ACE-031 should not automatically be considered equivalent to a selective myostatin inhibitor.

A selective myostatin inhibitor is designed primarily to interfere with myostatin itself, whereas ACE-031 operates through ActRIIB ligand sequestration and can therefore influence signaling involving multiple ligands.

This distinction is important when comparing research compounds because differences in molecular targets can produce substantially different biological and safety profiles.

ACE-031 Purity and Quality Testing

Researchers evaluating ACE-031 should examine available analytical documentation before using a research material.

Important quality parameters may include:

• Product identity
• Molecular structure
• Molecular weight
• Protein purity
• Batch number
• Analytical testing
• Product specifications
• Storage conditions

Because ACE-031 is a fusion protein, appropriate protein characterization is particularly important.

ACE-031 Certificate of Analysis (COA)

A Certificate of Analysis (COA) provides batch-specific information about a research material.

Depending on the supplier, an ACE-031 COA may contain:

• Product identification
• Batch or lot number
• Purity
• Molecular characterization
• Analytical methodology
• Test results
• Testing date
• Product specifications

Researchers should confirm that the documentation corresponds to the exact batch being evaluated.

ACE-031 Storage and Handling

ACE-031 is a protein-based research material, so researchers should follow product-specific storage and handling instructions.

Relevant considerations may include:

• Temperature
• Light exposure
• Moisture
• Freeze-thaw exposure
• Formulation
• Storage duration
• Container conditions

Generic storage recommendations should not replace the manufacturer’s documentation for the specific formulation.

Current State of ACE-031 Research

ACE-031 remains an experimental research compound.

Research has demonstrated interesting biological activity involving ActRIIB signaling and muscle-related pathways, but human development was limited by safety concerns. The clinical history demonstrates the importance of evaluating both biological activity and safety when manipulating broad signaling systems.

For researchers, ACE-031 remains relevant as a model for studying:

ActRIIB → myostatin/activin signaling → skeletal-muscle regulation → broader TGF-β biology

ACE-031 for Sale – High Purity Research Compound USA

If you are searching for ACE-031 for sale, sourcing from a verified manufacturer is essential to ensure purity, consistency, and reliable research outcomes. We supply high-quality research compounds for myostatin pathway studies, muscle biology research, and growth factor signaling analysis.

We operate under controlled laboratory standards.
We verify purity through analytical testing.
We provide full documentation for every production batch.

ace 031 peptide is a recombinant fusion protein designed to function as a soluble activin receptor type IIB (ActRIIB) decoy. It is widely utilized in research involving myostatin inhibition, skeletal muscle development, activin signaling pathways, and tissue growth regulation. Its unique mechanism makes it a valuable compound for investigating muscle mass regulation and related biological processes.

What You Receive

• ≥98% purity (analytically verified)
• Analytical validation and quality control testing
• Certificate of Analysis (COA) available per batch
• Laboratory-secured packaging
• Available in small batch or bulk wholesale quantities

Direct manufacturer sourcing ensures product integrity, traceability, and consistent long-term supply.

Bulk ACE-031 Supply

We support:

• Biotechnology research laboratories
• Pharmaceutical R&D organizations
• Academic research institutions
• Contract research organizations (CROs)
• Muscle biology and regenerative medicine research centers
• International distributors

Frequently Asked Questions About ACE-031

Is ACE-031 a Peptide?

Technically, ace 031 peptide is better classified as an ActRIIB-Fc fusion protein rather than a conventional short peptide.

What Is ACE-031 Used for in Research?

Research has investigated ACE-031 in relation to ActRIIB signaling, myostatin biology, skeletal muscle, muscle-wasting conditions, and TGF-β-superfamily pathways.

What Does ACE 031 Peptide Target?

ACE-031 acts as a soluble ActRIIB-based ligand trap and can interact with multiple ligands involved in ActRIIB signaling.

What Is Myostatin?

Myostatin, also called GDF-8, is a TGF-β-superfamily protein involved in regulating skeletal-muscle development.

Has ACE 031 Peptide Been Studied in Humans?

Yes. ACE-031 has been evaluated in human clinical studies, including studies involving healthy volunteers and Duchenne muscular dystrophy.

Why Was ace 031 peptide Studied for Duchenne Muscular Dystrophy?

Researchers investigated whether modifying ActRIIB signaling could influence muscle-related outcomes in a disease characterized by progressive muscle degeneration.

What Safety Concerns Were Reported?

Clinical research reported safety concerns including epistaxis and telangiectasias, contributing to discontinuation of a DMD clinical study.

What Should Researchers Check on an ACE-031 COA?

Check the product identity, molecular characteristics, purity, batch number, analytical methodology, test results, and applicable specifications.

Is ace 031 peptide available in bulk quantities?

Yes. We provide scalable manufacturing with volume-based pricing.

Do you provide Certificates of Analysis?

Yes. Each batch includes verifiable COA documentation.

Do you ship within the USA?

Yes. Orders are fulfilled through our U.S. distribution channel.

What purity level is provided?

≥98% purity verified through established analytical testing methods.

Why Choose Premium Bio Peptides?

Premium Bio Peptides provides research-focused educational resources covering peptides, proteins, molecular pathways, research compounds, and quality documentation.

Our goal is to make scientific information easier to understand by providing detailed research guides, product information, Certificates of Analysis, and educational resources.

Researchers should always review primary scientific literature and product-specific documentation when evaluating research materials.

Important Research-Use Statement

The information on this page is provided for scientific and educational purposes only. It is not medical advice and does not constitute a recommendation for human or veterinary use.

Research materials should only be handled by appropriately qualified individuals in accordance with applicable laws, regulations, laboratory procedures, safety requirements, and product-specific documentation.

Research materials are not intended for human or veterinary use, diagnosis, treatment, or prevention of disease.